Search

Your search keyword '"Opportunistic Infections"' showing total 21,069 results

Search Constraints

Start Over You searched for: Descriptor "Opportunistic Infections" Remove constraint Descriptor: "Opportunistic Infections"
21,069 results on '"Opportunistic Infections"'

Search Results

5. Re-engagement at Discharge 2 (ReCharge2)

7. Disseminated Cryptococcus over pancreas, lung, and brain: a case report.

8. Safety of Kidney Transplantation from Donors with HIV.

9. Clinical characteristics and prognosis of Talaromycosis marneffei associated immune reconstitution inflammatory syndrome in AIDS patients.

10. The role of trimethoprim/sulfamethoxazole in preventing opportunistic infections in systemic lupus erythematosus patients receiving low-level immunosuppressive treatment: an open-label, randomized, controlled trial.

11. Are people with HIV at advanced disease stages being left behind? A global survey.

12. The effect of corticosteroids in developing active pulmonary tuberculosis among patients with COVID-19.

13. Discrimination of primary and chronic cytomegalovirus infection based on humoral immune profiles in pregnancy.

14. Outcome of Pneumocystis Jirovecii pneumonia (PcP) in post-CAR-T patients with hematological malignancies.

15. Incidence and predictors of opportunistic infections among HIV-infected children on antiretroviral therapy at public health facilities of Southwest Ethiopia People Regional State, 2023: a multicenter retrospective follow-up study.

16. Characterization of Candida species isolated from clinical specimens: insights into virulence traits, antifungal resistance and molecular profiles.

17. Infection risk with JAK inhibitors in dermatoses: a meta‐analysis.

18. Localized Pneumocystis jirovecii pneumonia in a malnourished, non-HIV-infected man in the absence of any established or diagnosed immunosuppressive condition: a case report.

19. Incidence of opportunistic viral infections in hepatitis C virus nucleic acid test negative recipients of kidneys from hepatitis C virus nucleic acid test positive donors.

20. Respiratory Infections in the Rheumatic Patients: Epidemiology, Pathogenesis, Prophylaxis and Management.

21. Staphylococcus spp. as part of the microbiota and as opportunistic pathogen in free‐ranging black‐tuffed marmosets (Callithrix penicillata) from urban areas: Epidemiology, antimicrobial resistance, and pathology.

22. Time to major adverse drug reactions and its predictors among children on antiretroviral treatment at northwest Amhara selected public hospitals northwest; Ethiopia, 2023.

23. Nontuberculous mycobacterial myositis in dermatomyositis with long-term use of immunosuppressant: a case report.

24. Recurrent pulmonary nocardiosis due to Nocardia Otitidiscaviarum in a patient with isolated CD4 lymphocytopenia: a case report.

25. Development of a clinical risk score for the prediction of Pneumocystis jirovecii pneumonia in hospitalised patients.

26. The population pharmacokinetics of dolutegravir co‐administered with rifampicin in Thai people living with HIV: Assessment of alternative dosing regimens.

27. Nitazoxanide for Enterocytozoon bieneusi intestinal microsporidiosis.

28. Impact of HIV status on prognosis of malignancies among people living with HIV in Japan.

29. Brain abscesses: the first report of disseminated Nocardia beijingensis infection in an immunocompetent individual in China.

30. CROI 2024 BHIVA working group summary.

31. Optimizing the Synthesis of Novel Calcium Carbonate/Cobalt Oxide Nanocomposite With Highest Antifungal Activity.

32. AcuM and AcuK: The global regulators controlling multiple cellular metabolisms in a dimorphic fungus Talaromyces marneffei.

33. Mitochondrial chaperon TNF-receptor- associated protein 1 as a novel apoptotic regulator conferring susceptibility to Pneumocystis jirovecii pneumonia.

34. Performance of metagenomic Next-Generation Sequencing and metagenomic Nanopore Sequencing for the diagnosis of tuberculosis in HIV-positive patients.

35. Opportunistic Infections in HIV-Infected Children on Treatment in Southern Morocco: A 12-Years Retrospective Follow-up Study.

36. Pneumocystis jirovecii Pneumonia in Patients Treated for Solid Organ Malignancy.

37. Disseminated Mycobacterium avium Complex Infection Following CD3/CD20 Bispecific Antibody Therapy in a Patient With Follicular Lymphoma.

38. Phage against the Machine: The SIE-ence of Superinfection Exclusion.

39. Bioavailability of a novel sustained‐release pellet formulation of 5‐flucytosine in healthy‐fed participants for use in patients with cryptococcal meningitis.

40. A patient with positive anti‐IFN‐γ autoantibody and monoclonal gammaglobulinemia masquerading as multiple myeloma: Case report and literature review.

41. A rare case of invasive Enterococcus cecorum infection and related diagnostic difficulties.

42. Long-Term Safety of Risankizumab in Patients with Psoriatic Disease: A Comprehensive Analysis from Clinical Trials.

43. Feasibility of opportunistic colorectal cancer screening of hospitalized patients in tertiary care and community hospitals.

44. Non-HIV and Immunocompetent Patient with COVID-19 and Severe Pneumocystis jirovecii Pneumonia Co-Infection.

45. Clinical Significance, Species Distribution, and Temporal Trends of Nontuberculous Mycobacteria, Denmark, 1991–2022.

46. Primary antibody deficiencies.

47. PRINCIPAIS DIAGNÓSTICOS DE ENFERMAGEM EM PACIENTES COM AIDS EM PROCESSO DE FINITUDE: REVISÃO DE ESCOPO.

48. Predictors of HIV Viral Load Suppression After Enhanced Adherence Counseling, Nekemte, Ethiopia.

49. Determinants of survival time for HIV/AIDS patients in the pastoralist region of Borena: a study at Yabelo General Hospital, South East Ethiopia.

50. Identification of a genetic region linked to tolerance to MRSA infection using Collaborative Cross mice.

Catalog

Books, media, physical & digital resources